RSCF · Reflect Scientific, Inc.

OTC MARKETS - Real Time Price • USD

Reflect Scientific Inc (RSCF)

OTC MARKETS Life Sciences Tools & Services
Move probability → Options chain →
$0.06 +0.01 (+10.37%)
● Overnight
DAY'S RANGE $0.06
$0.05 $0.06
52-WEEK RANGE $0.06
$0.02 $0.07

What's happening

Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.

Key Statistics

Market Cap$5.4M
P/E (TTM1)—
EPS2 (TTM)$-0.00
Div Yield—
Beta31.58
Volume—
Open0.05
Prev Close0.06
Bid / Ask— / —
Next Earnings 2026-11-09

Analyst Recommendations

No analyst recommendation data available.

Performance Overview (Trailing returns vs S&P 500 benchmark)

YTD RETURN
RSCF +18.94%
vs S&P 500 +2.67%
1-YEAR RETURN
RSCF +3.09%
vs S&P 500 -8.94%
6-MONTH RETURN
RSCF +34.76%
3-MONTH RETURN
RSCF +49.52%

Valuation Measures & Ratios

Enterprise Value4$4.3M
Forward P/E5—
PEG Ratio60.11
Price / Sales (TTM1)3.12
Price / Book72.20
EV4 / Revenue2.53
EV4 / EBITDA43.49
Profit Margin-1.71%
Operating Margin-3.63%
Return on Equity (ROE8)-1.51%
Return on Assets (ROA9)-1.18%
Avg Volume (3M)80,970
Glossary — what these abbreviations mean
1. TTM
Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
2. EPS
Earnings per share — net income divided by diluted shares outstanding.
3. Beta
A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
4. EV (Enterprise Value)
Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
5. Forward P/E
Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
6. PEG Ratio
P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
7. Price / Book
Share price divided by book value (assets minus liabilities) per share.
8. ROE
Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
9. ROA
Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
10. MRQ
Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
11. YoY
Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.

Short Interest

Shares Short9,967
Change from Prior Settlement+653.36%
% of Float—
Days to Cover (Short Ratio)1.00

Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.

Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.

Price history

Events

Drag horizontally to zoom into a section; use Reset view to restore all observations.

Technical signal summary

Calculating from the latest year of daily price history…

Calculating…
Show Technical Analysis Breakdown ▾ 10 Indicators

Not investment advice — read several signals together.

Indicators None active

Add lines over the price chart or a panel below it. Your choices are saved on this device.

Starter sets
Trend
Oscillators
Volume/volatility
Loading chart…

History limited by data provider; markers are heuristics, not signals.

Peer and sector context

No reviewed peer group is available for this symbol.

Balanced evidence

A deterministic summary of sourced facts—not an AI verdict.

Potential strengths

Potential concerns

Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.

Financials

Income statement

Line item Sep '24Jun '24Mar '24Sep '23Jun '23Mar '23Sep '22Jun '22
Revenue $514.0K $590.1K $428.8K $525.9K $124.4K $241.1K $253.2K $555.6K
Gross profit $327.8K $358.6K $241.8K $330.0K $60.5K $127.5K $131.0K $359.8K
Operating income $99.2K $98.3K -$40.5K $80.9K -$180.8K -$147.8K -$133.2K $78.1K
Net income $109.9K $109.0K -$32.0K $86.3K -$181.1K -$147.8K -$133.9K $78.1K
EPS (diluted) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
EPS (basic) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00

Balance sheet

Line item Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23Mar '23Dec '22
Total assets $2.3M $2.3M $2.7M $2.7M $2.7M $2.5M $2.3M $2.4M
Total liabilities $258.5K $357.0K $816.2K $776.3K $631.8K $509.2K $111.3K $149.6K
Stockholders' equity $2.1M $2.0M $1.9M $1.9M $2.1M $2.0M $2.2M $2.3M
Total current assets $2.1M $2.1M $2.4M $2.4M $2.4M $2.4M $2.2M $2.3M
Total current liabilities $139.3K $216.1K $655.2K $596.4K $434.4K $509.2K $111.3K $149.6K
Cash & equivalents $1.0M $1.1M — $1.3M — — — —

Cash flow

Line item Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23Mar '23Dec '22
Operating cash flow -$72.3K $3.3K -$178.5K -$61.5K -$69.3K $209.7K -$182.9K $57.2K
Investing cash flow — — — — — — — —
Financing cash flow — — — — — — — —
Share-based compensation — — — $34.4K $6.9K $6.9K $6.9K $6.9K
Change in accounts receivable $161.5K -$224.4K $226.8K -$12.0K $27.5K -$15.7K -$21.0K $13.8K
Change in inventory -$60.0K -$115.2K -$21.4K $51.3K $43.9K $26.5K $53.3K -$106.7K

Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.

Institutional holders

SEC Form 13F filers holding RSCF as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.

Institutional ownership is not available for this symbol right now.

Insider activity

Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2015-07-02 to 2022-08-23

Insider purchases & sales, last 6 months

Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0

Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.

Insider roster

NameTitleMost Recent TransactionDateShares
BOYCE KIMCEO, CFOOpen market purchase2022-08-2317,250
MERRELL KEITH LCFOGrant / award2019-12-3081,000
Tait Thomas AVice PresidentGrant / award2019-12-30100,000
Moon William GDirectorGrant / award2019-12-30100,000

Recent transactions

DateInsiderTitleTransactionSharesPrice

Recent SEC filings

Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.

Source: SEC EDGAR submissions · updated 2026-10-21 23:36 UTC

FiledFormReport periodOfficial filing
2024-11-1210-Q2024-09-30 View on SEC.gov →
2024-08-1310-Q2024-06-30 View on SEC.gov →
2024-05-1310-Q2024-03-31 View on SEC.gov →
2024-03-2910-K2023-12-31 View on SEC.gov →
2023-11-0910-Q2023-09-30 View on SEC.gov →
2023-08-0810-Q2023-06-30 View on SEC.gov →
2023-05-1110-Q2023-03-31 View on SEC.gov →
2023-03-3110-K2022-12-31 View on SEC.gov →
2022-11-0910-Q2022-09-30 View on SEC.gov →
2022-08-2342022-08-23 View on SEC.gov →
2022-08-1142022-08-11 View on SEC.gov →
2022-08-1010-Q2022-06-30 View on SEC.gov →

Headlines about RSCF (Reflect Scientific, Inc.). Links open the publisher — we don’t host full articles.

SEC filings ↓

← Back to the full dashboard · My watchlist